<DOC>
	<DOCNO>NCT00161655</DOCNO>
	<brief_summary>The purpose study evaluate efficacy clear almost clear plaque plaque psoriasis patient , treat combination etanercept methotrexate compare etanercept alone .</brief_summary>
	<brief_title>Study Evaluating Etanercept Methotrexate Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Active plaque psoriasis involve &gt; 10 % body surface area and/or minimal screen PASI score 8 . Methotrexate &gt; 7.5 mg/week last 3 month Predominantly guttate , erythrodermic pustular psoriasis Other skin condition psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Arthritis</keyword>
</DOC>